Canopy Growth Corporation (CGC)

NYSEHealthcare

$1.13
-$0.01 (-0.9%)

January 21, 2026 at 19:16 UTC

Interactive Chart
CGC
1H
3H
6H
12H
1D
1W
1M
3M
6M
12M (YTD)
2Y
5Y
All
About Canopy Growth Corporation

Name

Canopy Growth Corporation

CEO

Luc Mongeau

Industry

Healthcare

Year Founded

2013

Employees

1,029

Canopy Growth Corporation is a cannabis company that organizes cultivation, processing, and distribution around audited routines rather than short-lived launches. Facilities are run as controlled environments with validated methods, and products are released only when they meet specifications that align with domestic and international rules. The portfolio is presented to adult consumers through licensed retail and to medical patients under physician guidance, with packaging and information designed to travel across channels without confusion. The company positions stewardship as a daily task: dosing is communicated plainly, storage and age-gating are enforced, and export programs move only where frameworks are clear. Partnerships and brand work are sized to fit compliance first, marketing second. Within consumer staples and healthcare, Canopy Growth frames cannabis as a regulated category that must earn trust through process, predictability, and patient record-keeping.

Analyst Ratings
Consensus Recommendation
Analyst consensus: 0 Buy, 8 Hold, 13 Sell
Buy0
Hold8
Sell13
Fundamentals & Financials
Revenue (TTM)
$278.6M
Net Income (TTM)
$-385.8M
EPS (TTM)
$-2.76
ROA (TTM)
-36.07%
Current Ratio
5.5
Dividend Yield
-

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement (Quarterly)
ItemQ3 2025
Revenue$66,683K
Cost of Sales$44,778K
Gross Profit$21,905K
Operating Income$-16,894K
Net Income$-1,639K
EPS$-0.01
Technical Indicators

Canopy Growth Corporation's Technical Indicators Summary

CGC is exhibiting a bearish trend overall, with the price currently trading below all major moving averages, including the 200-day EMA, which suggests sustained downward pressure. Momentum indicators such as the MACD show a sell signal, while the RSI and CCI remain in neutral territory, indicating limited buying strength. The ADX value is low, reflecting weak trend strength, and volatility, as measured by the ATR, remains elevated, pointing to continued price fluctuations. Additionally, the significant negative reading on the On-Balance Volume underscores selling pressure. Together, these factors confirm a cautious outlook with persistent bearish sentiment dominating the technical landscape.

Buy
0 signals
Neutral
8 signals
Sell
13 signals
Overall: Bearish62% Bearish signals
IndicatorValue
RSI (14)
45.32
Stochastic %K (14, 3, 3)
38.68
CCI (20)
-52.59
WPR (14)
-66.67
Momentum (10)
0.00
MFI
51.18
MACD Level (12, 26)
-0.03
Bollinger Bands
$1.00 - $1.52
ATR (14)
$0.12 (10.16%)
ADX (14)
10.14
OBV
-11,176,700
Simple Moving Averages
$1.22 - $1.32(5 indicators)
Exponential Moving Averages
$1.23 - $1.33(5 indicators)
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

From the start of the session, CGC's options board is heavily call-biased, with a very low PCR of 0.24. Early volumes are extremely muted, with CGC trading at just 0.16× its typical pace. CGC rises amid limited trading activity and a call-biased options market, suggesting bullish sentiment.

Price Change

from $1.15 close

+$0.02

Trading Volume

Below avg (17.6M)

2.8M

vs S&P 500 Today

Underperforming Market

-0.84%

52-Week Position

Lower range

18.8%

Updated: January 21, 2026 at 15:37 UTC

Quote Summary
OpenPrevious Close
$1.15$1.15
Day Range52 Week Range
$1.13 - $1.18$0.77 - $2.9
VolumeAvg. Volume
8.1M31.5M
Market CapP/E Ratio
$583.9M17.5
Peers & Related Assets